4.8 Review

Rethinking cancer nanotheranostics

期刊

NATURE REVIEWS MATERIALS
卷 2, 期 7, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/natrevmats.2017.24

关键词

-

资金

  1. Intramural Research Program, National Institute of Biomedical Imaging and Bioengineering, US National Institutes of Health (NIH)
  2. Department of Defense (CDMRP) [CA140666]
  3. National Science Foundation (CAREER) [NSF1552617]
  4. University of Georgia-Georgia Regents University (seed grant)
  5. NIH [R01EB022596, R01NS093314]
  6. Direct For Mathematical & Physical Scien
  7. Division Of Materials Research [1552617] Funding Source: National Science Foundation

向作者/读者索取更多资源

Advances in nanoparticle synthesis and engineering have produced nanoscale agents affording both therapeutic and diagnostic functions that are often referred to by the portmanteau 'nanotheranostics'. The field is associated with many applications in the clinic, especially in cancer management. These include patient stratification, drug-release monitoring, imaging-guided focal therapy and post-treatment response monitoring. Recent advances in nanotheranostics have expanded this notion and enabled the characterization of individual tumours, the prediction of nanoparticle-tumour interactions, and the creation of tailor-designed nanomedicines for individualized treatment. Some of these applications require breaking the dogma that a nanotheranostic must combine both therapeutic and diagnostic agents within a single, physical entity; instead, it can be a general approach in which diagnosis and therapy are interwoven to solve clinical issues and improve treatment outcomes. In this Review, we describe the evolution and state of the art of cancer nanotheranostics, with an emphasis on clinical impact and translation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据